rewirebio.iobenchmarks
Benchmark

ENIGMA 2024 BRCA evidence-calibration and curation study

Published-study grouping of the catalogued evaluation protocols. This grouping does not claim an executable suite, full-paper extraction or independent clinical validation.

5 evaluations · 39 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

5 recorded evaluations, 39 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.

View coverage and remaining gaps across all benchmarks

Results

Results are available, but no reviewed comparison panel is linked in this release.

All evaluations

5 evaluations · 39 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProtocol: BRCA1 generic BayesDel threshold evidence-code assignment
Dataset: BRCA1 functional reference calibration set
<10% Proportion (benign reference variants assigned BP4)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 generic BayesDel threshold comparator

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Results, BayesDel calibration, BP4 code would be assigned to <10% of BRCA1 and BRCA2 benign reference variants
Configuration: BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProtocol: BRCA1 generic BayesDel threshold evidence-code assignment
Dataset: BRCA1 functional reference calibration set
29% Proportion (benign reference variants assigned PP3)
percent · lower

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 generic BayesDel threshold comparator

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Results, BayesDel calibration, sentence 29% for BRCA1 and 36% for BRCA2 incorrectly assigned PP3
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
149 Count (interval: high, benign)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel ≥0.28, benign_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
12% Proportion (interval: high, benign)
percent · lower

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel ≥0.28, benign_fraction
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
7.09 Likelihood ratio (interval: high)
unitless · unknown

Uncertainty: 95% CI 6.06 to 8.30

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel ≥0.28, likelihood_ratio
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
377 Count (interval: high, pathogenic)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel ≥0.28, pathogenic_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
83% Proportion (interval: high, pathogenic)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel ≥0.28, pathogenic_fraction
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
946 Count (interval: low, benign)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel ≤0.15, benign_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
74% Proportion (interval: low, benign)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel ≤0.15, benign_fraction
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
0.1 Likelihood ratio (interval: low)
unitless · unknown

Uncertainty: 95% CI 0.07 to 0.14

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel ≤0.15, likelihood_ratio
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
34 Count (interval: low, pathogenic)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel ≤0.15, pathogenic_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
7% Proportion (interval: low, pathogenic)
percent · lower

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel ≤0.15, pathogenic_fraction
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
183 Count (interval: middle, benign)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel >0.15 and <0.28, benign_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
14% Proportion (interval: middle, benign)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel >0.15 and <0.28, benign_fraction
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
0.69 Likelihood ratio (interval: middle)
unitless · unknown

Uncertainty: 95% CI 0.51 to 0.94

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel >0.15 and <0.28, likelihood_ratio
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
45 Count (interval: middle, pathogenic)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel >0.15 and <0.28, pathogenic_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA1 BayesDel evidence calibration
Dataset: BRCA1 functional reference calibration set
10% Proportion (interval: middle, pathogenic)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA1, BayesDel >0.15 and <0.28, pathogenic_fraction
Configuration: BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProtocol: BRCA2 generic BayesDel threshold evidence-code assignment
Dataset: BRCA2 functional reference calibration set
<10% Proportion (benign reference variants assigned BP4)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 generic BayesDel threshold comparator

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Results, BayesDel calibration, BP4 code would be assigned to <10% of BRCA1 and BRCA2 benign reference variants
Configuration: BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProtocol: BRCA2 generic BayesDel threshold evidence-code assignment
Dataset: BRCA2 functional reference calibration set
36% Proportion (benign reference variants assigned PP3)
percent · lower

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 generic BayesDel threshold comparator

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Results, BayesDel calibration, sentence 29% for BRCA1 and 36% for BRCA2 incorrectly assigned PP3
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
29 Count (interval: high, benign)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, benign_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
10% Proportion (interval: high, benign)
percent · lower

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, benign_fraction
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
6.59 Likelihood ratio (interval: high)
unitless · unknown

Uncertainty: 95% CI 4.40 to 9.90

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, likelihood_ratio
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
88 Count (interval: high, pathogenic)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, pathogenic_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
66% Proportion (interval: high, pathogenic)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, pathogenic_fraction
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
216 Count (interval: low, benign)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≤0.18, benign_count

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Methods and evaluation design

Procedure, tasks and evaluated configurations

Evaluation design

Benchmarks bring together tasks and protocols. A task describes the biological question; a protocol defines a particular test.

These source-backed links do not make different protocols or scores interchangeable.

Baseline coverage

Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.

0 of 10 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.

Baseline status by linked protocol

Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)

Coverage is derived from release 2026-11-21-c8bea25e5abb. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.

Run this benchmark

Choose a concrete protocol before running an evaluation. Its inputs, split and scoring rules determine which results can be compared.

Run instructions

No runnable recipe has been reviewed for this benchmark. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID uc-clinical-20260930-benchmark-enigma-study.

Source locator: Table2; calibration Results; pilot curation

Related records

Suggest a correction